EF Hutton analyst Constantine Davides reiterates Innoviva (NASDAQ:INVA) with a Buy and maintains $22.5 price target.
- Headlines
- EF Hutton Reiterates Buy on Innoviva, Maintains $22.5 Price Target
EF Hutton Reiterates Buy on Innoviva, Maintains $22.5 Price Target
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Write a comment
0 0 0
LikeLoveLaughing CryRespectEmmSadAngry
Tap to Select a Mood
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
Use the share button in your browser
to share the page with your friends
Tap here to share
No comments yet. Write one.
Related Stocks Related Stocks
Symbol Mini Chart Latest Price
Unlock the Full List
Latest
02:03
The USA Treasury auctioned four-month Treasury bills, with a winning yield of 4.195% (compared to 4.230% on December 26), and a bid-to-cover ratio of 3.04 (previously 2.91).
02:01
Traders: Argentina's country risk has decreased by 27 basis points to 608 basis points, the lowest level in six years.
02:00
The FBI states that the attacks in New Orleans and Las Vegas do not appear to be connected.